Indolylmaleimide derivatives as a new class of anti-leishmanial agents: synthesis and biological evaluation.

Leishmaniasis is a neglected tropical disease, primarily affecting poor and developing countries. The present therapeutic approach faces various limitations, such as concerns regarding toxicity, route of administration, and the emergence of drug resistance. Therefore, there is a critical need to identify novel scaffolds to combat this fatal parasitic infection.